Global Injectables Market: Insights & Forecast with Potential Impact of COVID-19 (2022-2026)
The global injectables market is estimated to reach US$836.6 billion in 2026, progressing at a CAGR of 10.95%, over the period 2022-2026. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive the growth of the market. However, the market growth would be challenged by stringent regulatory guidelines, emergence of alternative drug delivery methods and manufacturing complexity and high operational cost. A few notable trends may include accelerating prevalence of chronic diseases, growing adoption of self-injectable devices, upswing in drug shortages and advancements in technology.
Depending on the type, the global injectables market can be bifurcated into two main categories: innovator and generic. Further, generic injectables market can be split into Anti-Infectives (AI), Antineoplastics + Immunomodulators (AN+IM), Alimentary Tract + Metabolic (AT+Mb), Blood Related (BR), Central Nervous System (CNS), Musculoskeletal (Msk) and others, on the basis of therapy.
The fastest growing regional market is North America due to the improvements in healthcare infrastructure coupled with growing demand for injectables on account of high presence of a large number of patients with chronic diseases such as diabetes and arthritis which require frequent drug dosing and increasing research and development activities for the development of innovative injectables drugs.
Scope of the report:
- The report provides a comprehensive analysis of the global injectables market segmented on the basis of type and region.
- The major regional and country markets (North America, Europe, China, India and Rest of the World) have been analyzed.
- The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
- The competitive landscape of the market, along with the company profiles of leading players (Novartis International AG, Pfizer Inc., Fresenius SE & Co. KGaA, Baxter International Inc., Shanghai Fosun Pharmaceutical Group Co. Ltd. (Gland Pharma Ltd.) and Hikma Pharmaceuticals PLC) are also presented in detail.
- Injectable Drug Manufacturers & Distributers
- Pharmaceutical, Biopharmaceutical & Biotechnological Companies
- End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers & Others)
- Research and Development (R&D) Organizations
- Government Bodies & Regulating Authorities
- 1. Market Overview
- 1.1 Introduction
- Table 1: Routes of Drug Administration
- 1.2 Parenteral Route of Drug Administration
- 1.3 Types of Parenteral Routes of Administration
- Table 2: Types of Parenteral Routes of Administration
- 1.4 Formulation of Injectable
- 1.5 Factors Favoring the Absorption of Injectable Drugs
- Table 3: Factors Favoring the Absorption of Injectable Drugs
- 1.6 Types of Injectable Drug Products
- Table 4: Types of Injectable Drug Products
- 1.7 Advantages of Injectable Drugs
- Table 5: Advantages of Injectable Drugs
- 2. Impact of COVID-19
- 2.1 Growing Investments in the R&D Pipeline of Injectables
- Table 6: Percentage of Drugs in R&D Pipeline Worldwide by Delivery Route (2020)
- 2.2 Surging Adoption of Plasma Therapy
- Table 7: Global Plasma Therapy Market Forecast (2019-2024)
- 2.3 Rising Usage of Smart Syringes
- Table 8: Global Smart Syringes Market (2018-2027)
- 2.4 Accelerating Vaccine Production
- Table 9: Reported Vaccine Production Capacity (Q4 2020-2023)
- 3. Global Market Analysis
- 3.1 Global Injectables Market by Value
- Table 10: Global Injectables Market by Value (2017-2021)
- 3.2 Global Injectables Market Forecast by Value
- Table 11: Global Injectables Market Forecast by Value (2022-2026)
- 3.3 Global Injectables Market by Type
- Table 12: Global Injectables Market by Type (2021)
- 3.3.1 Global Innovator Injectables Market by Value
- Table 13: Global Innovator Injectables Market by Value (2017-2021)
- 3.3.2 Global Innovator Injectables Market Forecast by Value
- Table 14: Global Innovator Injectables Market Forecast by Value (2022-2026)
- 3.3.3 Global Generic Injectables Market by Value
- Table 15: Global Generic Injectables Market by Value (2017-2021)
- 3.3.4 Global Generic Injectables Market Forecast by Value
- Table 16: Global Generic Injectables Market Forecast by Value (2022-2026)
- 3.3.5 Global Generic Injectables Market by Therapy
- Table 17: Global Generic Injectables Market by Therapy (2021)
- 3.3.6 Global Anti-Infective Injectables Market by Value
- Table 18: Global Anti-Infective Injectables Market by Value (2017-2021)
- 3.3.7 Global Anti-Infective Injectables Market Forecast by Value
- Table 19: Global Anti-Infective Injectables Market Forecast by Value (2022-2026)
- 3.3.8 Global Antineoplastic+ Immunomodulator Injectables Market by Value
- Table 20: Global Antineoplastic+ Immunomodulator Injectables Market by Value (2017-2021)
- 3.3.9 Global Antineoplastic+ Immunomodulator Injectables Market Forecast by Value
- Table 21: Global Antineoplastic+ Immunomodulator Injectables Market Forecast by Value (2022-2026)
- 3.3.10 Global Alimentary Tract + Metabolic Injectables Market by Value
- Table 22: Global Alimentary Tract + Metabolic Injectables Market by Value (2017-2021)
- 3.3.11 Global Alimentary Tract + Metabolic Injectables Market Forecast by Value
- Table 23: Global Alimentary Tract + Metabolic Injectables Market Forecast by Value (2022-2026)
- 3.3.12 Global Blood Related Injectables Market by Value
- Table 24: Global Blood Related Injectables Market by Value (2017-2021)
- 3.3.13 Global Blood Related Injectables Market Forecast by Value
- Table 25: Global Blood Related Injectables Market Forecast by Value (2022-2026)
- 3.3.14 Global Central Nervous System Injectables Market by Value
- Table 26: Global Central Nervous System Injectables Market by Value (2017-2021)
- 3.3.15 Global Central Nervous System Injectables Market Forecast by Value
- Table 27: Global Central Nervous System Injectables Market Forecast by Value (2022-2026)
- 3.3.16 Global Musculoskeletal Injectables Market by Value
- Table 28: Global Musculoskeletal Injectables Market by Value (2017-2021)
- 3.3.17 Global Musculoskeletal Injectables Market Forecast by Value
- Table 29: Global Musculoskeletal Injectables Market Forecast by Value (2022-2026)
- 3.4 Global Injectables Market by Region
- Table 30: Global Injectables Market by Region (2021)
- 3.5 Global Generic Injectables Market by Region
- Table 31: Global Generic Injectables Market by Region (2021)
- 4. Regional Market Analysis
- 4.1 North America
- 4.1.1 North America Injectables Market by Value
- Table 32: North America Injectables Market by Value (2017-2021)
- 4.1.2 North America Injectables Market Forecast by Value
- Table 33: North America Injectables Market Forecast by Value (2022-2026)
- 4.1.3 North America Generic Injectables Market Forecast by Value
- Table 34: North America Generic Injectables Market Forecast by Value (2021-2026)
- 4.1.4 The U.S. Injectables Market by Value
- Table 35: The U.S. Injectables Market by Value (2017-2021)
- 4.1.5 The U.S. Injectables Market Forecast by Value
- Table 36: The U.S. Injectables Market Forecast by Value (2022-2026)
- 4.1.6 The U.S. Injectables Market by Type
- Table 37: The U.S. Injectables Market by Type (2021)
- 4.1.7 The U.S. Innovator Injectables Market Forecast by Value
- Table 38: The U.S. Innovator Injectables Market Forecast by Value (2021-2026)
- 4.1.8 The U.S. Generic Injectables Market Forecast by Value
- Table 39: The U.S. Generic Injectables Market Forecast by Value (2021-2026)
- 4.2 Europe
- 4.2.1 Europe Injectables Market by Value
- Table 40: Europe Injectables Market by Value (2017-2021)
- 4.2.2 Europe Injectables Market Forecast by Value
- Table 41: Europe Injectables Market Forecast by Value (2022-2026)
- 4.2.3 Europe Generic Injectables Market Forecast by Value
- Table 42: Europe Generic Injectables Market Forecast by Value (2021-2026)
- 4.3 China
- 4.3.1 China Injectables Market by Value
- Table 43: China Injectables Market by Value (2017-2021)
- 4.3.2 China Injectables Market Forecast by Value
- Table 44: China Injectables Market Forecast by Value (2022-2026)
- 4.3.3 China Injectables Market by Type
- Table 45: China Injectables Market by Type (2021)
- 4.3.4 China Generic Injectables Market Forecast by Value
- Table 46: China Generic Injectables Market Forecast by Value (2021-2026)
- 4.3.5 China Innovator Injectables Market Forecast by Value
- Table 47: China Innovator Injectables Market Forecast by Value (2021-2026)
- 4.4 India
- 4.4.1 India Injectables Market by Value
- Table 48: India Injectables Market by Value (2017-2021)
- 4.4.2 India Injectables Market Forecast by Value
- Table 49: India Injectables Market Forecast by Value (2022-2026)
- 4.4.3 India Generic Injectables Market Forecast by Value
- Table 50: India Generic Injectables Market Forecast by Value (2021-2026)
- 4.5 RoW
- 4.5.1 RoW Injectables Market by Value
- Table 51: RoW Injectables Market by Value (2017-2021)
- 4.5.2 RoW Injectables Market Forecast by Value
- Table 52: RoW Injectables Market Forecast by Value (2022-2026)
- 4.5.3 RoW Generic Injectables Market Forecast by Value
- Table 53: RoW Generic Injectables Market Forecast by Value (2021-2026)
- 5. Market Dynamics
- 5.1 Growth Drivers
- 5.1.1 Increasing Geriatric Population
- Table 54: Global Population 65 Years and Above (2017-2021)
- 5.1.2 Upsurge in Demand for Convenient Drug Delivery
- Table 55: Global Spending on Injectables (2015 v/s 2020)
- 5.1.3 Expanding Use of Biologics
- Table 56: Global Biologics Market Revenue (2016-2022)
- 5.1.4 Rising Healthcare Expenditure
- Table 57: Global Healthcare Expenditure Per Capita (2017-2021)
- 5.1.5 Surging Incidence of Cancer Cases
- Table 58: Global Cancer Prevalence (2018-2023)
- 5.2 Key Trends and Developments
- 5.2.1 Accelerating Prevalence of Chronic Diseases
- Table 59: Global Diabetes Prevalence (2010-2045)
- 5.2.2 Growing Adoption of Self-Injectable Devices
- Table 60: Distribution of the Global Injectable Drug Delivery Market by Device (2016 v/s 2025)
- 5.2.3 Upswing in Drug Shortages
- Table 61: Percentage of New Drug Shortages in the U.S. (2017-2021)
- 5.2.4 Advancements in Technology
- 5.3 Challenges
- 5.3.1 Stringent Regulatory Guidelines
- 5.3.2 Emergence of Alternative Drug Delivery Methods
- 5.3.3 Manufacturing Complexity & High Operational Cost
- 6. Competitive Landscape
- 6.1 North America Market
- 6.1.1 The U.S. Generic Injectables Market Value Share by Key Players
- Table 62: The U.S. Generic Injectables Market Value Share by Key Players (2021)
- 6.1.2 The U.S. Generic Injectables Market Volume Share by Key Players
- Table 63: The U.S. Generic Injectables Market Volume Share by Key Players (2021)
- 7. Company Profiles
- 7.1 Novartis International AG
- 7.1.1 Business Overview
- 7.2 Pfizer Inc.
- 7.2.1 Business Overview
- 7.3 Fresenius SE & Co. KGaA
- 7.3.1 Business Overview
- 7.4 Baxter International Inc.
- 7.4.1 Business Overview
- 7.5 Shanghai Fosun Pharmaceutical Group Co. Ltd. (Gland Pharma Ltd.)
- 7.5.1 Business Overview
- 7.6 Hikma Pharmaceuticals PLC
- 7.6.1 Business Overview
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook